SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-043967
Filing Date
2014-06-26
Accepted
2014-06-26 21:00:10
Documents
1
Period of Report
2014-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5876
  Complete submission text file 0001209191-14-043967.txt   7201
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Issuer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address KERYX BIOPHARMACEUTICALS, INC. 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address (212) 531-5965
Tarnok Michael P. (Reporting) CIK: 0001413525 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30929 | Film No.: 14943888